O
BIIB icon

OppenheimerFunds’s Biogen BIIB Stock Holding History

OppenheimerFunds’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$112M Sell
472,260
-318,818
-40% -$100M 0.14% 149
2018
Q4 		$238M Sell
791,078
-73,304
-8% -$23.4M 0.34% 75
2018
Q3 		$305M Sell
864,382
-82,558
-9% -$28.4M 0.35% 70
2018
Q2 		$275M Sell
946,940
-5,471
-0.6% -$1.54M 0.33% 76
2018
Q1 		$261M Sell
952,411
-9,777
-1% -$3.03M 0.33% 79
2017
Q4 		$307M Sell
962,188
-23,762
-2% -$7.62M 0.37% 66
2017
Q3 		$309M Sell
985,950
-39,157
-4% -$11.6M 0.38% 69
2017
Q2 		$278M Buy
1,025,107
+2,214
+0.2% +$585K 0.34% 79
2017
Q1 		$280M Sell
1,022,893
-16,739
-2% -$4.73M 0.34% 84
2016
Q4 		$295M Sell
1,039,632
-291,331
-22% -$86.4M 0.37% 72
2016
Q3 		$417M Buy
1,330,963
+6,562
+0.5% +$1.94M 0.52% 39
2016
Q2 		$320M Sell
1,324,401
-321,851
-20% -$84.8M 0.42% 60
2016
Q1 		$429M Sell
1,646,252
-45,925
-3% -$12.1M 0.57% 40
2015
Q4 		$518M Buy
1,692,177
+9,353
+0.6% +$2.69M 0.66% 26
2015
Q3 		$491M Buy
1,682,824
+115,464
+7% +$38.1M 0.66% 23
2015
Q2 		$633M Buy
1,567,360
+164,460
+12% +$66M 0.73% 21
2015
Q1 		$592M Sell
1,402,900
-120,340
-8% -$47.4M 0.66% 24
2014
Q4 		$517M Buy
1,523,240
+71,310
+5% +$23.1M 0.58% 29
2014
Q3 		$480M Sell
1,451,930
-17,960
-1% -$5.92M 0.53% 46
2014
Q2 		$463M Buy
1,469,890
+238,880
+19% +$71.9M 0.51% 47
2014
Q1 		$377M Sell
1,231,010
-45,700
-4% -$14.5M 0.44% 51
2013
Q4 		$357M Sell
1,276,710
-972,990
-43% -$252M 0.43% 52
2013
Q3 		$542M Buy
2,249,700
+1,657,780
+280% +$371M 0.36% 70
2013
Q2 		$127M Buy
+591,920
New +$126M 0.18% 146

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OppenheimerFunds's BIIB Position: Q1 2019 in Review

OppenheimerFunds reduced its Biogen (BIIB) stake by 40% in Q1 2019, selling an estimated $100M and leaving 472,260 shares worth $112M. The position accounts for 0.14% of the portfolio, ranked #149.

OppenheimerFunds first reported a position in BIIB in Q2 2013 and has held it in 24 quarters since. The position peaked at $633M in Q2 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • OppenheimerFunds held 472,260 shares of Biogen worth $112M as of Q1 2019.
  • OppenheimerFunds sold 318,818 Biogen shares in Q1 2019, an estimated $100M.
  • Biogen made up 0.14% of OppenheimerFunds's portfolio in Q1 2019, its #149 holding.
  • OppenheimerFunds first reported a position in Biogen in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Biogen position peaked at $633M in Q2 2015.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.